Akita, Keitaro <br/><br/>
Impact of reduced-dose prasugrel vs. standard-dose clopidogrel on in-hospital outcomes of percutaneous coronary intervention in 62 737 patients with acute coronary syndromes: a nationwide registry study in Japan.  [electronic resource] 

 -  European heart journal. Cardiovascular pharmacotherapy  07 2020 
 - 231-238 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2055-6845 
<br/><br/><label>Standard No.: </label>10.1093/ehjcvp/pvz056  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Coronary Syndrome--diagnosis<br/>Aged<br/>Aged, 80 and over<br/>Clopidogrel--administration & dosage<br/>Coronary Thrombosis--mortality<br/>Databases, Factual<br/>Female<br/>Hemorrhage--chemically induced<br/>Hospital Mortality<br/>Hospitalization<br/>Humans<br/>Incidence<br/>Japan--epidemiology<br/>Male<br/>Middle Aged<br/>Percutaneous Coronary Intervention--adverse effects<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Prasugrel Hydrochloride--administration & dosage<br/>Propensity Score<br/>Prospective Studies<br/>Registries<br/>Risk Assessment<br/>Risk Factors<br/>ST Elevation Myocardial Infarction--diagnosis<br/>Time Factors<br/>Treatment Outcome